Literature DB >> 19787822

Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease.

Daniela De Nitto, Ivan Monteleone, Eleonora Franzè, Francesco Pallone, Giovanni Monteleone.   

Abstract

Celiac disease (CD), an enteropathy caused by dietary gluten in genetically susceptible individuals, is histologically characterized by villous atrophy, crypt cell hyperplasia, and increased number of intra-epithelial lymphocytes. The nature of CD pathogenesis remains unclear, but recent evidence indicates that both innate and adaptive immune responses are necessary for the phenotypic expression and pathologic changes characteristic of CD. Extensive studies of molecules produced by immune cells in the gut of CD patients have led to identification of two cytokines, namely interleukin (IL)-15 and IL-21, which are thought to play a major role in orchestrating the mucosal inflammatory response in CD. Here we review the current knowledge of the expression and function of IL-15 and IL-21 in CD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787822      PMCID: PMC2754507          DOI: 10.3748/wjg.15.4609

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  57 in total

1.  The first large population based twin study of coeliac disease.

Authors:  L Greco; R Romino; I Coto; N Di Cosmo; S Percopo; M Maglio; F Paparo; V Gasperi; M G Limongelli; R Cotichini; C D'Agate; N Tinto; L Sacchetti; R Tosi; M A Stazi
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.

Authors:  M Bitzer; G von Gersdorff; D Liang; A Dominguez-Rosales; A A Beg; M Rojkind; E P Böttinger
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

3.  TCR specificity dictates CD94/NKG2A expression by human CTL.

Authors:  Bana Jabri; Jeanette M Selby; Horia Negulescu; Leanne Lee; Arthur I Roberts; Andrew Beavis; Miguel Lopez-Botet; Ellen C Ebert; Robert J Winchester
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

4.  Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.

Authors:  G Monteleone; A Kumberova; N M Croft; C McKenzie; H W Steer; T T MacDonald
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

5.  Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function.

Authors:  J Parrish-Novak; S R Dillon; A Nelson; A Hammond; C Sprecher; J A Gross; J Johnston; K Madden; W Xu; J West; S Schrader; S Burkhead; M Heipel; C Brandt; J L Kuijper; J Kramer; D Conklin; S R Presnell; J Berry; F Shiota; S Bort; K Hambly; S Mudri; C Clegg; M Moore; F J Grant; C Lofton-Day; T Gilbert; F Rayond; A Ching; L Yao; D Smith; P Webster; T Whitmore; M Maurer; K Kaushansky; R D Holly; D Foster
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

6.  Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease.

Authors:  G Monteleone; S L Pender; E Alstead; A C Hauer; P Lionetti; C McKenzie; T T MacDonald
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

7.  Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study.

Authors:  Alessio Fasano; Irene Berti; Tania Gerarduzzi; Tarcisio Not; Richard B Colletti; Sandro Drago; Yoram Elitsur; Peter H R Green; Stefano Guandalini; Ivor D Hill; Michelle Pietzak; Alessandro Ventura; Mary Thorpe; Debbie Kryszak; Fabiola Fornaroli; Steven S Wasserman; Joseph A Murray; Karoly Horvath
Journal:  Arch Intern Med       Date:  2003-02-10

Review 8.  Coeliac disease: dissecting a complex inflammatory disorder.

Authors:  Ludvig M Sollid
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

9.  Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease.

Authors:  B Jabri; N P de Serre; C Cellier; K Evans; C Gache; C Carvalho; J F Mougenot; M Allez; R Jian; P Desreumaux; J F Colombel; C Matuchansky; H Cugnenc; M Lopez-Botet; E Vivier; A Moretta; A I Roberts; E C Ebert; D Guy-Grand; N Brousse; J Schmitz; N Cerf-Bensussan
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

10.  Interleukin 15 mediates epithelial changes in celiac disease.

Authors:  L Maiuri; C Ciacci; S Auricchio; V Brown; S Quaratino; M Londei
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

View more
  10 in total

Review 1.  Cutting-edge issues in celiac disease and in gluten intolerance.

Authors:  N Bizzaro; R Tozzoli; D Villalta; M Fabris; E Tonutti
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 2.  Testing for antireticulin antibodies in patients with celiac disease is obsolete: a review of recommendations for serologic screening and the literature.

Authors:  Sarada L Nandiwada; Anne E Tebo
Journal:  Clin Vaccine Immunol       Date:  2013-01-30

3.  Altered expression of cytokine signaling pathway genes in peripheral blood cells of alcohol dependent subjects: preliminary findings.

Authors:  Robert D Beech; Jie Qu; Janine J Leffert; Aiping Lin; Kwangik A Hong; Julie Hansen; Sheila Umlauf; Shrikant Mane; Hongyu Zhao; Rajita Sinha
Journal:  Alcohol Clin Exp Res       Date:  2012-04-04       Impact factor: 3.455

4.  Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients.

Authors:  Tamara Vorobjova; Oivi Uibo; Kaire Heilman; Raivo Uibo
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

Review 5.  Intestinal stem cells and celiac disease.

Authors:  Anna Chiara Piscaglia
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

Review 6.  IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction.

Authors:  Bana Jabri; Valérie Abadie
Journal:  Nat Rev Immunol       Date:  2015-11-16       Impact factor: 53.106

7.  Modeling of celiac disease immune response and the therapeutic effect of potential drugs.

Authors:  Oleg O Demin; Sergey V Smirnov; Victor V Sokolov; Lourdes Cucurull-Sanchez; Cesar Pichardo-Almarza; M Victoria Flores; Neil Benson; Oleg V Demin
Journal:  BMC Syst Biol       Date:  2013-07-05

8.  Potential blood-based markers of celiac disease.

Authors:  Hanna Bragde; Ulf Jansson; Mats Fredrikson; Ewa Grodzinsky; Jan Söderman
Journal:  BMC Gastroenterol       Date:  2014-10-09       Impact factor: 3.067

Review 9.  The Role of Gluten in Celiac Disease and Type 1 Diabetes.

Authors:  Gloria Serena; Stephanie Camhi; Craig Sturgeon; Shu Yan; Alessio Fasano
Journal:  Nutrients       Date:  2015-08-26       Impact factor: 5.717

10.  Modeling the pharmacokinetic-pharmacodynamic relationship of the monoclonal anti-macaque-IL-15 antibody Hu714MuXHu in cynomolgus monkeys.

Authors:  Wei J Pan; Hong Li; Jim J Xiao; Michelle J Horner; Herve N Lebrec; Eric A Butz; Arunan Kaliyaperumal; Tsui C Cheah; Robert C Ortiz; Samantha P Prokop; Sabina A Buntich; Babette M Boren; Suzanne T Wolford; Wayne H Tsuji; Larry C Wienkers; Kathleen Köck
Journal:  Pharmacol Res Perspect       Date:  2016-01-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.